Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

BACKGROUND: Many recent therapeutic interventions are necessary to improve the treatment of hepatocellular carcinoma (HCC), including immunotherapy, which seems to offer one of the new realistic therapeutic modalities. This study aims to investigate the optimization of immunotherapy for HCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabeen, Abdulwahab Ali, Abdel-Hamid, Fatma Farag, El-Houseini, Motawa Eisa, Fathy, Shadia Abdel-Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918270/
https://www.ncbi.nlm.nih.gov/pubmed/27508176
http://dx.doi.org/10.2147/JHC.S56012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918270/
https://www.ncbi.nlm.nih.gov/pubmed/27508176
http://dx.doi.org/10.2147/JHC.S56012

Ejemplares similares